SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-021833
Filing Date
2017-01-27
Accepted
2017-01-27 16:17:55
Documents
5
Period of Report
2017-01-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d315370d8k.htm 8-K 20766
2 EX-5.1 d315370dex51.htm EX-5.1 7977
3 EX-10.1 d315370dex101.htm EX-10.1 150443
4 EX-99.1 d315370dex991.htm EX-99.1 6134
5 GRAPHIC g315370g33p82.jpg GRAPHIC 3247
  Complete submission text file 0001193125-17-021833.txt   191191
Mailing Address 11119 N. TORREY PINES ROAD, STE 125 LA JOLLA CA 92037
Business Address 11119 N. TORREY PINES ROAD, STE 125 LA JOLLA CA 92037 (858) 500-8800
Kura Oncology, Inc. (Filer) CIK: 0001422143 (see all company filings)

IRS No.: 611547851 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37620 | Film No.: 17553937
SIC: 2834 Pharmaceutical Preparations